Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome

Victor J Santiago, Aleksandr Lazaryan, Brian L McClune, Robert W. McKenna, Elizabeth L Courville

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In this retrospective study, we quantified the hematogone (normal B-lineage precursor) population by flow cytometric immunophenotyping in post-transplant bone marrow biopsy specimens from adult patients who received an autologous stem cell transplant for either plasma cell myeloma (n = 57) or diffuse large B-cell lymphoma (n = 73). The majority of patients (80%) had <5% marrow hematogones post-transplant. Extreme (>10%) hematogone percentages were quite rare, seen in only four patients, and were not associated with disease progression. There was a positive association between the post-transplant day and hematogone percentage within the first year after transplant, and a negative association thereafter. Plasma cell myeloma patients with ≥5% hematogones in any post-transplant flow cytometry study had a worse overall survival as did plasma cell myeloma patients with increased hematogones (as defined by percentile) at 100 days post-transplant. These findings require further study, ideally in a prospective study design.

Original languageEnglish (US)
Pages (from-to)958-966
Number of pages9
JournalLeukemia and Lymphoma
Volume59
Issue number4
DOIs
StatePublished - Jul 24 2018

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Multiple Myeloma
Stem Cells
Bone Marrow
Transplants
Immunophenotyping
Disease Progression
Flow Cytometry
Retrospective Studies
Prospective Studies
Biopsy
Survival
Population

Keywords

  • Autologous stem cell transplant
  • Autotransplant
  • B-lineage precursors
  • Diffuse large B-cell lymphoma
  • Hematogones
  • Multiple myeloma
  • Plasma cell myeloma

PubMed: MeSH publication types

  • Journal Article

Cite this

Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome. / Santiago, Victor J; Lazaryan, Aleksandr; McClune, Brian L; McKenna, Robert W.; Courville, Elizabeth L.

In: Leukemia and Lymphoma, Vol. 59, No. 4, 24.07.2018, p. 958-966.

Research output: Contribution to journalArticle

@article{c5983d74e743475c90272abf7d64614a,
title = "Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome",
abstract = "In this retrospective study, we quantified the hematogone (normal B-lineage precursor) population by flow cytometric immunophenotyping in post-transplant bone marrow biopsy specimens from adult patients who received an autologous stem cell transplant for either plasma cell myeloma (n = 57) or diffuse large B-cell lymphoma (n = 73). The majority of patients (80{\%}) had <5{\%} marrow hematogones post-transplant. Extreme (>10{\%}) hematogone percentages were quite rare, seen in only four patients, and were not associated with disease progression. There was a positive association between the post-transplant day and hematogone percentage within the first year after transplant, and a negative association thereafter. Plasma cell myeloma patients with ≥5{\%} hematogones in any post-transplant flow cytometry study had a worse overall survival as did plasma cell myeloma patients with increased hematogones (as defined by percentile) at 100 days post-transplant. These findings require further study, ideally in a prospective study design.",
keywords = "Autologous stem cell transplant, Autotransplant, B-lineage precursors, Diffuse large B-cell lymphoma, Hematogones, Multiple myeloma, Plasma cell myeloma",
author = "Santiago, {Victor J} and Aleksandr Lazaryan and McClune, {Brian L} and McKenna, {Robert W.} and Courville, {Elizabeth L}",
year = "2018",
month = "7",
day = "24",
doi = "10.1080/10428194.2017.1352094",
language = "English (US)",
volume = "59",
pages = "958--966",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome

AU - Santiago, Victor J

AU - Lazaryan, Aleksandr

AU - McClune, Brian L

AU - McKenna, Robert W.

AU - Courville, Elizabeth L

PY - 2018/7/24

Y1 - 2018/7/24

N2 - In this retrospective study, we quantified the hematogone (normal B-lineage precursor) population by flow cytometric immunophenotyping in post-transplant bone marrow biopsy specimens from adult patients who received an autologous stem cell transplant for either plasma cell myeloma (n = 57) or diffuse large B-cell lymphoma (n = 73). The majority of patients (80%) had <5% marrow hematogones post-transplant. Extreme (>10%) hematogone percentages were quite rare, seen in only four patients, and were not associated with disease progression. There was a positive association between the post-transplant day and hematogone percentage within the first year after transplant, and a negative association thereafter. Plasma cell myeloma patients with ≥5% hematogones in any post-transplant flow cytometry study had a worse overall survival as did plasma cell myeloma patients with increased hematogones (as defined by percentile) at 100 days post-transplant. These findings require further study, ideally in a prospective study design.

AB - In this retrospective study, we quantified the hematogone (normal B-lineage precursor) population by flow cytometric immunophenotyping in post-transplant bone marrow biopsy specimens from adult patients who received an autologous stem cell transplant for either plasma cell myeloma (n = 57) or diffuse large B-cell lymphoma (n = 73). The majority of patients (80%) had <5% marrow hematogones post-transplant. Extreme (>10%) hematogone percentages were quite rare, seen in only four patients, and were not associated with disease progression. There was a positive association between the post-transplant day and hematogone percentage within the first year after transplant, and a negative association thereafter. Plasma cell myeloma patients with ≥5% hematogones in any post-transplant flow cytometry study had a worse overall survival as did plasma cell myeloma patients with increased hematogones (as defined by percentile) at 100 days post-transplant. These findings require further study, ideally in a prospective study design.

KW - Autologous stem cell transplant

KW - Autotransplant

KW - B-lineage precursors

KW - Diffuse large B-cell lymphoma

KW - Hematogones

KW - Multiple myeloma

KW - Plasma cell myeloma

UR - http://www.scopus.com/inward/record.url?scp=85025481302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025481302&partnerID=8YFLogxK

U2 - 10.1080/10428194.2017.1352094

DO - 10.1080/10428194.2017.1352094

M3 - Article

C2 - 28728454

AN - SCOPUS:85025481302

VL - 59

SP - 958

EP - 966

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 4

ER -